Similar Search Results

Expected Profits and the Scientific Novelty of Innovation

Dranove, David; Garthwaite, Craig; Hermosilla, Manuel - 2022

Innovation policy involves trading off monopoly output and pricing in the short run in exchange for incentives for …

Persistent link: https://www.econbiz.de/10013309194

The Role of Assets in Place : Loss of Market Exclusivity and Investment

Higgins, Matthew John; Kronlund, Mathias; Park, Ji Min; … - 2022

We utilize a novel identification strategy to analyze the impact of assets in place on firms' decisions for future projects. We exploit the context in the pharmaceutical industry, where the loss of market exclusivity for a branded drug can be used to separate the impact of cash flows generated...

Persistent link: https://www.econbiz.de/10013406834

Public-Private Interaction and the Productivity of Pharmaceutical Research

Cockburn, Iain M.; Henderson, Rebecca M. - 2021

We examine the impact of publicly funded biomedical research on the in-house research of the for-profit pharmaceutical industry. Qualitative analysis of the history of the discovery and development of a sample of 21 significant drugs, and a program of interviews with senior managers and...

Persistent link: https://www.econbiz.de/10013223878

The Cost of Us Pharmaceutical Price Reductions : A Financial Simulation Model of R&D Decisions

Abbott, Thomas A.; Vernon, John A. - 2021

Previous empirical studies that have examined the links between pharmaceutical price controls, profits, cash flows, and investment in research and development (R&D) have been largely based on retrospective statistical analyses of firm- and/or industry-level data. These studies, which have...

Persistent link: https://www.econbiz.de/10013227913

Private and Social Returns to R&D : Drug Development and Demographics

Benmelech, Efraim; Eberly, Janice; Krieger, Joshua; … - 2022

Investment in intangible capital—in particular, research and development—increased dramatically since the 1990s. However, productivity growth remains sluggish in recent years. One potential reason is that a significant share of the increase in intangible investment is geared toward consumer...

Persistent link: https://www.econbiz.de/10014264816

Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research

Furman, Jeffrey L. - 2014

While there is widespread agreement among economists and management scholars that knowledge spillovers exist and have important economic consequences, researchers know substantially less about the quot;micro mechanismsquot; of spillovers -- about the degree to which they are geographically...

Persistent link: https://www.econbiz.de/10012752114

Missing Novelty in Drug Development

Krieger, Joshua - 2018

This paper provides evidence that risk aversion leads pharmaceutical firms to underinvest in radical innovation. We …

Persistent link: https://www.econbiz.de/10012919316

The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Canada, 2000-2011

Lichtenberg, Frank R. - 2015

of decline across cancer sites. I analyze the effect that pharmaceutical innovation had on premature cancer mortality in … Canada during the period 2000-2011, by investigating whether the cancer sites that experienced more pharmaceutical innovation … that pharmaceutical innovation during the period 1985-1996 reduced the number of years of potential life lost to cancer …

Persistent link: https://www.econbiz.de/10013021477

Pharmaceutical Innovation and the Longevity of Australians : A First Look

Lichtenberg, Frank R. - 2008

We examine the impact of pharmaceutical innovation on the longevity of Australians during the period 1995-2003. Due to …

Persistent link: https://www.econbiz.de/10012771909

Are National Patent Laws the Blossoming Rain?

Qian, Yi - 2014

Research on the effects of patent protection on innovation and technology transfer in the cross-country pharmaceutical … industry adds to our understanding of the underlying forces driving a country's innovation level. Qian (2007) constructs a … not stimulate domestic innovation, as estimated by the US patent awards (both raw counts and citation-weighted) and …

Persistent link: https://www.econbiz.de/10013069398